Abstract
Introduction The Czech National Centre represents new activities in the field of pharmacotherapy in paediatrics and neonatology in CR and Slovakia as well as the successful ongoing involvement of the Czech Charles University scientific team in the conect4children (c4c) consortium within the collaborative pan-European network (CzechNatHub). Currently, this project aims to facilitate CzechNatHub’s sustainability and business plans within and beyond the c4c-periods.
Methodology The project is within the Europe-wide Innovative Medicines Initiative2 (IMI2)2 with joint funding from the European Federation of Pharmaceutical Industry and Associations (EFPIA) and the European Commission The coordination centre for the Czech Republic is the Department of Pediatrics and Inherited Metabolic Disorders of the 1st Faculty of Medicine of Charles University and the General Hospital in Prague is involved in the WP 2,6,7 (education, infrastructure, and research) and WP4 (expert group) with a focus on the c4c maturity matrix (strategic feasibility advice, network, data standards, education, patient and public involvement) using nationally based logistic analysis.
Results Key c4c points were identified to support the skills (beneficiaries) in the field of clinical studies of the entire study team (CRO), to define the role of the study coordinator and his responsibilities and practical skills (industry through AIFP), to teach young doctors, research nurses (Enpr-EMA) and non-medical experts and the public (YPAGNET) to work together as a team where everyone has a defined role and responsibilities, and to develop links with academic societies (Czech Paediatric Society, ESDPPP), and to find funding. The spring multi-stakeholder meeting will bring all this together.
Conclusion The Czech National Centre has become a coordinating academic centre established for pharmacotherapy in the paediatric population for the Czech Republic and Slovakia.
Acknowledgement Horizon 2020 c4c IMI2, on behalf of Czech consortium.